Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 221-230 of 406 for multiple

Edit search filters
  1. A Study Evaluating The Addition Of Venetoclax (ABT-199) To Patients With Multiple Myeloma Who Are Receiving Bortezomib And Dexamethasone As Standard Therapy

    Rochester, MN

  2. Phase 2 Study To Evaluate The Oral Combination Of Ixazomib (MLN9708) With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Or Relapsed And/or Refractory Multiple Myeloma

    Rochester, MN

  3. Addition Of Daratumumab To Combination Of Bortezomib And Dexamethasone In Participants With Relapsed Or Refractory Multiple Myeloma

    Jacksonville, FL

  4. A Study Of Multiple Therapies In Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer

    Rochester, MN

  5. A Study To Assess The Safety And Tolerability Of Single And Multiple Doses Of KAN-101 In Celiac Disease Patients

    Rochester, MN

  6. A Study To Evaluate The Safety And Effectiveness Of Anti-CD38 CAR-T In Relapsed Or Refractory Multiple Myeloma Patients

    Jacksonville, FL, Rochester, MN

  7. A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide And Dexamethasone Versus Placebo Plus Lenalidomide And Dexamethasone In Adult Patients With Relapsed And/or Refractory Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  8. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, And Dexamethasone To Pomalidomide And Dexamethasone In Refractory Or Relapsed And Refractory Multiple Myeloma Patients

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Effectiveness Of AMG 397 In Subjects With Multiple Myeloma, NHL, And AML

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study Comparing JNJ-79635322 And An Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody In Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer